Yes, polycystic ovary syndrome (PCOS) is an endocrine disorder. It is one of the most common hormonal conditions in women, affecting an estimated 10 to 13% of women of reproductive age worldwide. While the name suggests it’s primarily an ovarian problem, PCOS is driven by disruptions across multiple hormonal systems, including the brain’s signaling to the ovaries, insulin regulation, and androgen production.
Why PCOS Is Classified as an Endocrine Disorder
An endocrine disorder is any condition caused by hormones being produced in the wrong amounts or not functioning properly. PCOS fits this definition on multiple levels. The core issue is excess androgen production (often called “male hormones,” though all women produce them in small amounts), combined with problems in how the brain signals the ovaries to release eggs. These aren’t isolated glitches. They form an interconnected hormonal cycle where one imbalance worsens the others.
The Endocrine Society, which is the world’s leading professional organization for hormone-related medicine, lists PCOS as a primary endocrine condition. Diagnosis requires ruling out other endocrine disorders that can look similar, including thyroid disease, high prolactin levels, and a genetic condition called non-classical congenital adrenal hyperplasia.
The Hormonal Chain Reaction Behind PCOS
The disruption starts in the hypothalamus, a region of the brain that controls reproductive hormones. In women with PCOS, the hypothalamus sends out abnormally fast and strong pulses of a signal called GnRH, which tells the pituitary gland to release luteinizing hormone (LH). This rapid-fire signaling causes LH levels to climb while another hormone, follicle-stimulating hormone (FSH), stays low or drops. The resulting high LH-to-FSH ratio is a hallmark of the condition.
That imbalance has three downstream effects. First, excess LH drives the ovaries’ outer cells to ramp up androgen production, leading to the elevated testosterone levels responsible for symptoms like acne and excess hair growth. Second, without enough FSH, developing follicles in the ovaries stall before they can mature and release an egg, which is why periods become irregular or stop. Third, LH stimulates the ovaries to produce a growth factor that further increases androgen output and encourages the formation of the small, fluid-filled cysts visible on ultrasound.
Research in neuroendocrinology has identified a specific brain chemical called kisspeptin as a key driver. Kisspeptin levels in the hypothalamus are consistently elevated in women with PCOS and in animal models of the condition. Kisspeptin is the master switch for GnRH pulses, so higher levels keep the whole chain running too fast. Androgens themselves also feed back into the hypothalamus to further speed up GnRH signaling, creating a self-reinforcing loop.
Insulin Resistance as a Hormonal Driver
PCOS isn’t just a reproductive hormone problem. Insulin, the hormone that moves sugar from your blood into cells, plays a surprisingly central role. Many women with PCOS have insulin resistance, meaning their cells don’t respond normally to insulin. The body compensates by producing more and more of it, and those high insulin levels directly worsen androgen excess in several ways.
Insulin acts as a “co-pilot” alongside LH in the ovaries, amplifying androgen production beyond what LH alone would cause. It also stimulates the adrenal glands to produce extra androgens, reduces the liver’s production of a protein that binds and deactivates testosterone in the bloodstream, and interferes with progesterone’s ability to slow down the GnRH pulse generator in the brain. The result is a vicious cycle: insulin resistance increases androgens, and those androgens may further impair metabolic function.
This metabolic dimension is why PCOS carries risks well beyond the reproductive system. Women with PCOS face a significantly higher risk of cardiovascular disease. A large meta-analysis published in the Journal of the American Heart Association found that PCOS was associated with a 68% higher odds of cardiovascular disease overall, a 2.5-fold increase in heart attack risk, and a 71% higher risk of stroke compared to women without the condition. Insulin resistance, high blood pressure, abnormal cholesterol, and early-onset diabetes all contribute to this elevated risk.
How PCOS Is Diagnosed
The current international guidelines, updated in 2023, use criteria that require at least two of three features: signs of excess androgens (either visible symptoms like acne and excess hair, or elevated levels on a blood test), irregular or absent ovulation, and polycystic-appearing ovaries on ultrasound. If you have both androgen excess and irregular cycles, the diagnosis can be made without an ultrasound at all.
A notable update in the 2023 guidelines is that a blood test measuring anti-Müllerian hormone (AMH) can now be used as an alternative to ultrasound for identifying polycystic ovarian features. AMH is produced by the small follicles in the ovaries, so elevated levels reflect the same ovarian picture that ultrasound would show. However, guidelines recommend using either AMH or ultrasound, not both, to avoid overdiagnosis. AMH testing is also not recommended for adolescents, where only androgen excess and irregular cycles are needed for diagnosis.
How Treatment Targets the Hormonal Imbalances
Because PCOS is fundamentally an endocrine disorder, treatment focuses on correcting or managing the specific hormonal imbalances involved. The approach depends on which symptoms are most bothersome and whether you’re trying to conceive.
For insulin resistance, metformin (a medication originally developed for type 2 diabetes) is commonly prescribed. It lowers insulin levels, which in turn reduces the hormonal drive behind excess androgen production. While not officially licensed for PCOS in some countries, it is widely used off-label and can improve both metabolic markers and menstrual regularity.
For managing androgen-related symptoms like unwanted hair growth and hair thinning, combined oral contraceptive pills are a first-line option. They suppress LH production from the pituitary, reduce ovarian androgen output, and increase the liver protein that binds free testosterone. When contraceptive pills aren’t enough, anti-androgen medications can be added, though these are not safe during pregnancy.
For women trying to get pregnant, treatment focuses on restoring ovulation. When medications alone don’t work, a minor surgical procedure called laparoscopic ovarian drilling can be used. This involves applying heat or laser to small areas of androgen-producing tissue on the ovaries, which lowers testosterone and LH levels while raising FSH, often restoring normal ovulation cycles.
Lifestyle changes, particularly weight management and regular physical activity, remain foundational. Even modest weight loss can improve insulin sensitivity enough to shift the hormonal balance, reduce androgen levels, and restart ovulation in some women. This underscores how deeply PCOS is rooted in the endocrine system: changing one metabolic input can ripple through the entire hormonal chain.